美国前列腺穿刺活检后感染并发症的地理差异:基于私人保险人群的队列研究结果
研究利用MarketScan数据库分析2010至2015年193,490例经直肠超声引导前列腺穿刺活检(TRUS-PB)患者,评估30天内急诊就诊或住院的感染并发症(尿路感染、前列腺炎、脓毒症)。全国未调整感染率保持稳定,但各州间存在显著差异,康涅狄格州最低(每100次活检0.64),西弗吉尼亚州最高(2.34)。多因素分析显示较高的Elixhauser评分和患者年龄与感染并发症风险升高相关(P<0.05)。
要点
- 2010至2015年全国TRUS-PB后感染并发症率稳定,急诊就诊率从0.4/100次活检降至0.2(P=0.83),住院率从1.2降至1.1(P=0.58)。
- 各州未调整感染并发症率差异显著,康涅狄格州最低(0.64/100次活检),西弗吉尼亚州最高(2.34/100次活检)。
- 较高的Elixhauser评分和患者年龄与感染并发症风险升高相关(P<0.05)。
核心结论
- 前列腺穿刺活检导致的感染并发症率相对稳定,但在州级水平存在显著差异。
研究设计与样本
- 基于MarketScan私人保险数据库的回顾性队列研究,纳入2010至2015年接受经直肠超声引导前列腺穿刺活检的193,490例患者。
主要发现
- 全国未调整急诊就诊率从2010年每100次活检0.4降至2015年0.2(P=0.83),住院率从1.2降至1.1(P=0.58)。
- 康涅狄格州未调整感染并发症率最低为每100次活检0.64,西弗吉尼亚州最高为2.34。
- 多因素分析显示较高的Elixhauser评分和患者年龄与感染并发症风险升高相关(P<0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To elucidate regional trends of infectious complications following transrectal ultrasound prostate biopsy (TRUS-PB) from a national, privately-insured database. MATEREIAL AND METHODS: Using Market Scan, we identified all men who underwent TRUS-PB from 2010 to 2015. Infectious complications (UTI, prostatitis, sepsis) occurring 30 days after the prostate biopsy from emergency room (ER) visits or hospital admissions constituted the primary outcomes. We analyzed unadjusted and adjusted rates of infectious complications from ER visits and hospital admissions per 100 prostate biopsies by state. Multivariable logistic regression analyses were used to identify patient covariates associated with infectious complications. RESULTS: During the study interval, we identified 193,490 patients who underwent TRUS-PB. The mean age was 57.6 years (SD: 5.0). Over time the unadjusted national rates of infectious complications remained similar from 0.4 ER visits per 100 prostate biopsies in 2010 -0.2 in 2015 (P = 0.83), and 1.2 hospital admissions per 100 prostate biopsies in 2010 to 1.1 in 2015 (P= 0.58). Connecticut had the lowest unadjusted infectious complication rate per 100 biopsies at 0.64, whereas West Virginia had the highest at 2.34. Multivariable analysis revealed higher Elixhauser status and patient age were associated with higher odds of infectious complications (P<0.05). CONCLUSIONS: While rates of infectious complications attributable to prostate biopsies remain relatively stable, significant variation exists at the state level regarding this adverse outcome.
引用
- Morrison JC, Sax-Bolder A, Gershman B, et al. Geographic Variation of Infectious Complications Following Prostate Biopsy in The United States: Results From a Population-Based Cohort of Privately Insured Patients. Urology. 2022. PMID: 35809698. doi:10.1016/j.urology.2022.05.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。